Cromos Pharma provides clinical trial management services for drug and medical device development in the field of gastroenterology
We offer a wide range of services, including study design, site selection and management, patient recruitment, data management, medical writing, and regulatory submissions. Cromos Pharma has expertise in the complex regulatory and ethical issues involved in gastroenterology research, including the use of endoscopic procedures, patient safety, and informed consent.
We have vast experience in the conduct of clinical trials for inflammatory bowel disease (IBD), including both Crohn’s disease and Ulcerative Colitis. Cromos Pharma has a strong track record of designing and managing clinical trials to evaluate the safety and efficacy of new IBD treatments, including biologics and small molecules.
We also have experience in evaluating treatments for liver disease, including hepatitis B and C, nonalcoholic steatohepatitis (NASH), and cirrhosis. These conditions can have serious health consequences and require careful monitoring and management. Cromos Pharma can help design and manage clinical trials to evaluate the safety and efficacy of new liver disease treatments, including antivirals, immunomodulators, and other therapies.
In addition, we have experience in conducting clinical trials for other digestive disorders, such as gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and gastrointestinal cancers. Cromos Pharma can provide customized solutions to meet the specific needs of each study, whether it is a large multinational trial or a small, single-center study.
Our extensive knowledge of the regulatory and ethical issues involved in gastroenterology research and can help design and manage clinical trials to evaluate the safety and efficacy of new treatments. Cromos Pharma’s expertise in IBD, liver disease, and other digestive disorders makes it an essential partner for pharmaceutical and medical device companies looking to bring new products to market.
